Standout Papers

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerat... 2019 2026 2021 2023 203
  1. Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis (2019)
    William J. Sandborn, Filip Baert et al. Gastroenterology

Immediate Impact

53 standout
Sub-graph 1 of 19

Citing Papers

Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
2025 Standout
Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species
2025 Standout
3 intermediate papers

Works of Siddharth Bhatia being referenced

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
2019 Standout

Author Peers

Author Last Decade Papers Cites
Siddharth Bhatia 356 53 111 214 17 446
L. Z. Cooper 187 32 108 219 17 462
Steven Polyak 185 81 102 143 21 507
Geller Sa 122 25 122 102 28 485
Jamie Inshaw 235 77 182 36 17 436
Gregor Novak 363 3 115 281 27 475
Neil Fraser 80 15 85 156 18 492
Susan W. Serjeantson 187 9 120 76 18 465
Fernando Brenes 144 72 171 41 14 412
O Danne 114 31 83 184 10 392
F. Amri 79 6 38 192 33 467

All Works

Loading papers...

Rankless by CCL
2026